The standardization of biochemical measurement procedures in multiple myeloma is necessary for reliable prognostic stratification of patients in multicentric trials. Our study compared results of albumin, beta 2 microglobulin and monoclonal immunoglobulin measurement from six centers which provide treatment for multiple myeloma in the Czech republic and attempted ro standardize the analytic procedures.